As peritoneal fibrosis is a frequent evolution of PD, which can limit the efficacy of dialytic treatment [82], it would be useful to validate PTP4A1 as a prognostic biomarker to predict the progression of renal fibrosis in PD. The gene discussed is PTP4A1; the disease is Peritoneal Fibrosis.